Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 12, Issue 9
|
pp. 8640–8651
Exenatide inhibits NF-κB and attenuates ER stress in diabetic cardiomyocyte models
Back to article
Figure 3
(3 of 5)
−
100%
+
Figure 3.
Exenatide reduces ER stress and the activation of NF-κB signaling pathway.
(
A
–
C
) qPCR assay for ATF6, IRE1 and PERK transcription. (
D
) ELISA assay for NF-κB activity. (
E
–
F
) Immunofluorescence staining for NF-κB. *P<0.05.